Landos Biopharma

YTD

ALL

Why Robinhood?

You can watch LABP and buy or sell other stocks, ETFs, and their options commission-free!

About LABP

Landos Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of novel, oral, once-daily therapeutics for patients with certain immunology diseases. It offers NX-13, a novel, oral, gut-restricted compound for the treatment of inflammatory bowel disease, which targets the NLRX1 pathway.

CEO

Gregory Oakes, MBA

CEOGregory Oakes, MBA

Employees

—

Employees—

Headquarters

Roanoke, Virginia

HeadquartersRoanoke, Virginia

Founded

2017

Founded2017

Employees

—

Employees—

LABP Key Statistics

Market cap

10.57M

Market cap10.57M

Price-Earnings ratio

-5.74

Price-Earnings ratio-5.74

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$22.94

52 Week high$22.94

52 Week low

$21.90

52 Week low$21.90

People also own

Based on the portfolios of people who own LABP. This list is generated using Robinhood data, and it’s not a recommendation.

SNDL

Cenntro Electric Group Li…